ArticleSkeletal radiology2025
MR neurography findings of brachial plexopathy following total shoulder arthroplasty.
Article in Skeletal radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo characterize nerve injury patterns following total shoulder arthroplasty (TSA).
methodsThis retrospective study reviewed brachial plexus MR neurography (MRN) in patients with brachial plexopathy within 180 days post TSA from 2016 to 2023. Patients with pre-existing neurologic symptoms or without available electrodiagnostic testing (EDX) data were excluded. MRN findings were extracted from the original report and independently reviewed by a second, musculoskeletal fellowship trained radiologist.
resultsA total of 27 patients (15F/12 M, mean age 67) were included. MRN and EDX-confirmed nerve injury localization matched in 13 patients, with nerve hyperintensity and/or enlargement identified in 7 cases at the plexus proper and 6 cases at the branch nerve level (suprascapular, axillary, radial, median). Nerve impingement by screw (n = 3) or extruded cement (n = 1) and mass effects including soft tissue edema (n = 1), hematoma (n = 2), or joint effusion (n = 2) were identified. MRN detected muscle denervation in 8 of 19 patients with EMG abnormalities, with a median TSA-to-MRN interval of 62.5 days (range, 19-95) versus 3 days (range, 2-155) in those without denervation on MRN (p = 0.003). Inter-rater reliability demonstrated substantial to almost perfect agreement for MRN assessments, except for cord hyperintensity. All patients were clinically followed up: 3 had complete symptomatic resolution and 21/27 reported partial improvement at a mean follow-up time of 25.5 months.
conclusionsMRN findings closely correlated with EDX-confirmed clinical diagnoses in cases with MRN abnormalities. Additionally, MRN identified secondary findings, such as local mass effect on nerve segments, that can guide management.
Indexed as
Identifiers
40358731What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.